We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




7T MRI Used in Brain Disorder Research Collaboration

By LabMedica International staff writers
Posted on 16 Nov 2011
A 7-T magnetic resonance imaging (MRI) investigational scanner will be used to support academic research on functional brain mapping, high-resolution anatomic imaging of the brain, spectroscopy of the brain, assessment of tumor response to treatment, and cardiovascular imaging.

GE Healthcare (Chalfont St. More...
Giles, UK) and University of Iowa Health Care (Iowa City, USA) announced that they would collaborate on ultra-high-field MRI to study brain disorders. The purchase of the GE equipment for research use will be funded with a National Institutes of Health (NIH) high-end instrumentation grant awarded to Vincent Magnotta, PhD, in the department of radiology at University of Iowa Hospitals and Clinics in Iowa City (IA, USA).

The GE 7 T MR imaging scanner will provide ultra-high-field whole body scanning capabilities for MRI research. It will be housed in the University’s new Pappajohn Biomedical Discovery Institute, currently under construction. It is being acquired by the University of Iowa to support the research efforts of 33 funded US National Institutes of Health (NIH; Bethesda, MD, USA) investigators from five colleges (medicine, engineering, public health, liberal arts and sciences, and business) with more than 40 NIH grants. This group of researchers from University of Iowa has a wide range of interests including functional brain mapping, high-resolution anatomical imaging of the brain, spectroscopy of the brain, evaluation of tumor response to treatment, and cardiovascular imaging.

“We are honored and delighted to work with the University of Iowa to provide ultra-high-field strength MR imaging capabilities to help study patients with a variety of brain disorders,” said Jacques Coumans PhD, general manager of GE Healthcare’s MRI business. “Our 7 T MRI research system has the abilities to provide increased image resolution and sensitivity to help accelerate translational research. This collaboration is an excellent representation of how academic-industrial partnerships can help define new directions with the goal of facilitating more immediate health improvements and better outcomes.”

Three medical device vendors participated in a competitive proposal process for the research scanner purchase.

Related Links:
GE Healthcare
University of Iowa Health Care



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Human Estradiol Assay
Human Estradiol CLIA Kit
New
Rapid Test Reader
DIA5000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: Prof. Nicholas Schwab has found a biomarker that can predict treatment outcome of glatirameracetate in MS patients (Photo courtesy of Uni MS - M. Ibrahim)

Simple Genetic Testing Could Predict Treatment Success in Multiple Sclerosis Patients

Multiple sclerosis (MS) patients starting therapy often face a choice between interferon beta and glatiramer acetate, two equally established and well-tolerated first-line treatments. Until now, the decision... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.